December 20, 2006,The Food and Drug Administration (FDA) today approved Invega (paliperidone) extended-release tablets for the treatment of schizophrenia. Paliperidone is a new molecular entity, which...
28 Nov 2006,A currently favoured cognitive model of the abnormal behaviours and experiences characteristic of schizophrenia suggests that they may be linked to a disturbance in the effects of context....